Graf Akcie WST (West Pharmaceutical Services, Inc.). Diskuze k akciím WST. Aktuální informace WST.

Základní informace o společnosti West Pharmaceutical Services, Inc. (Akcie WST)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 29.79B
Hodnota podniku (EV) 32.83B
Tržby 2.523B
EBITDA 754.6M
Zisk 519.2M
Růst v tržbách Q/Q 37.25 %
Růst v tržbách Y/Y 29.66 %
P/E (Cena vůči ziskům) 58.12
Forward P/E 10.83
EV/Sales 13.01
EV/EBITDA 43.51
EV/EBIT 52.13
PEG 4.03
Price/Sales 11.81
P/FCF 105.05
Price/Book 16.07
Účetní hodnota na akcii 25.36
Hotovost na akcii 8.42
FCF vůči ceně 0.95 %
Počet zaměstnanců 9,200
Tržba na zaměstnance 274.185k
Profit margin 16.13 %
Operating margin 23.87 %
Gross margin 35.76 %
EBIT margin 24.96 %
EBITDA margin 29.91 %
EPS - Zisk na akcii 7.01
EPS - Kvartální růst 96.80 %
EPS - Očekávaný růst příští rok 56.52 %
Return on assets 18.79 %
Return on equity 27.93 %
ROIC 16.63 %
ROCE 25.59 %
Dluhy/Equity 0.51
Čistý dluh/EBITDA -1.20
Current ratio 3.13
Quick Ratio 2.39
Volatilita 2.60
Beta 0.71
RSI 36.32
Cílová cena analytiků 298
Známka akcie (dle analytiků) 2.14
Insider ownership 0.64 %
Institutional ownership 95.10 %
Počet akcií 73.979M
Procento shortovaných akcií 1.21 %
Short ratio 2.51 %
Dividenda 0.68
Procentuální dividenda 0.17 %
Dividenda/Zisk 9.70 %
Obchodovaná od 1978
Země United States

Finanční výsledky akcie WST

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,146.9$1,839.9$1,717.4$1,599.1$1,509.1$1,399.8
Cost Of Goods Sold$1,379.1$1,234.2$1,172$1,086.2$1,007.7$944
Gross Profit$767.8$605.7$545.4$512.9$501.4$455.8
Research And Development Expenses$46.9$38.9$40.3$39.1$36.8$34.1
SG&A Expenses$302$272.7$262.9$246$239.6$233
Other Operating Income Or Expenses$-12$2.5$-1.9$-2$-29.8$-60.1
Operating Expenses$1,740$1,543.3$1,477.1$1,373.3$1,313.9$1,271.2
Operating Income$406.9$296.6$240.3$225.8$195.2$128.6
Total Non-Operating Income/Expense$-5.6$-4.8$0.4$-3.4$-5.4$-12.5
Pre-Tax Income$401.3$291.8$240.7$222.4$189.8$116.1
Income Taxes$72.5$59$41.4$80.9$54.4$26.3
Income After Taxes$328.8$232.8$199.3$141.5$135.4$89.8
Other Income------
Income From Continuous Operations$346.2$241.7$206.9$150.7$143.6$95.6
Income From Discontinued Operations------
Net Income$346.2$241.7$206.9$150.7$143.6$95.6
EBITDA$516$400$344.7$322.5$285.9$218.5
EBIT$406.9$296.6$240.3$225.8$195.2$128.6
Basic Shares Outstanding747474747372
Shares Outstanding767575767574
Basic EPS$4.68$3.27$2.80$2.04$1.96$1.33
EPS - Earnings Per Share$4.57$3.21$2.74$1.99$1.91$1.30
# 2020 2019 2018 2017 2016 2015
Current Ratio2.72883.09923.15262.66012.66352.1435
Long-term Debt / Capital0.120.13950.12310.13340.16830.1827
Debt/Equity Ratio0.13760.16360.14040.15390.20460.2912
Gross Margin35.763232.920331.757332.074333.225132.5618
Operating Margin18.952916.120413.992114.120512.93499.187
EBIT Margin18.952916.120413.992114.120512.93499.187
EBITDA Margin24.034721.740320.07120.167618.945115.6094
Pre-Tax Profit Margin18.692115.859614.015413.907812.5778.294
Net Profit Margin16.125613.136612.04739.42419.51566.8295
Asset Turnover0.76850.78580.86790.85840.87910.8258
Inventory Turnover Ratio4.29235.23635.46395.04745.05625.2126
Receiveable Turnover5.5725.76235.95916.31567.52677.7166
Days Sales In Receivables65.505863.342861.251357.793848.494147.3003
ROE - Return On Equity18.668115.363614.817711.774412.85019.3369
Return On Tangible Equity20.211316.836216.288813.098714.487510.8427
ROA - Return On Assets12.391710.322910.45538.098.36495.6398
ROI - Return On Investment16.427813.220712.993810.203810.68697.6309
Book Value Per Share25.060821.230818.843517.319415.287314.1618
Operating Cash Flow Per Share1.36351.04240.3540.54830.04730.3656
Free Cash Flow Per Share0.73910.75460.6911.092-0.43890.1196